Biofrontera (BFRI)
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the...
- Open
- 1.220
- High
- 1.240
- Low
- 1.180
- Prev. Close
- 1.210
- Volume
- 337.80K
- Turnover
- 409.56K
- Avg Price
- 1.212
- Bid/Ask Ratio
- --
- Amplitude
- 4.96%
- 52wk High
- 1.270
- Volume Ratio
- 1.80
- Turnover Ratio
- 3.69%
Biofrontera Analyst Rating
View moreForecast & Rating
May 19, 2026Price forecast
$5.88381.56%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- TradingView · Aug 6 at 06:00 AM
BFRI Q2'26 Earnings: EPS estimate is (0.10) USD
- PUBT · Aug 5 at 04:20 PM
Biofrontera to report Q2 financial results, host conference call
- PUBT · Jun 17 at 03:06 PM
Biofrontera shareholders approve amended 2021 omnibus incentive plan share increase to 8,750,000
- nasdaq · Jun 2 at 12:25 PM
Biofrontera (BFRI) Q1 2026 Earnings Transcript
- pressetext · May 29 at 05:15 PM
BIOFRONTERA REPORTS RESULTS FOR THE FIRST QUARTER OF 2026
- benzinga_article · May 19 at 09:34 AM
This Hanover Insurance Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday
